PerkinElmer Cash Conversion Cycle 2011-2026 | PKI

Annual Cash Conversion Cycle PerkinElmer

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
92.2	87.6	92.9	91.3	250	-	121	113	99.6	110	-	110	108	101	94.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
250	87.6	113

Quarterly Cash Conversion Cycle PerkinElmer

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
146	139	149	-	149	146	156	-	155	132	127	-	153	170	157	71.6	172	105	50.8	-	118	123	133	83.3	124	121	127	76.3	117	112	116	78.5	132	133	127	68.7	127	122	66.8	-	112	107	115	70.6	113	110	112	72	111	108	112	72.8	108	105	93	69.5	102	94.5	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
172	50.8	115

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Bioventus BVS	224	$ 8.87	2.9 %	$ 591 M	USA
Charles River Laboratories International CRL	65	$ 151.97	-2.34 %	$ 7.53 B	USA
Castle Biosciences CSTL	45.9	$ 25.83	1.06 %	$ 717 M	USA
CareDx, Inc CDNA	51.5	$ 17.32	1.82 %	$ 923 M	USA
DexCom DXCM	134	$ 66.34	3.27 %	$ 25.9 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	42.5	$ 103.85	0.27 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	42.4	$ 14.95	1.22 %	$ 452 M	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 17.29	-3.3 %	$ 2.24 B	USA
Guardant Health GH	79.6	$ 87.18	1.98 %	$ 10.9 B	USA
Anixa Biosciences ANIX	275	$ 2.84	0.35 %	$ 92.2 K	USA
Danaher Corporation DHR	77.5	$ 191.39	2.17 %	$ 136 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
ICON Public Limited Company ICLR	62	$ 97.61	-0.73 %	$ 8.05 B	Irlanda
IQVIA Holdings IQV	73.9	$ 164.89	0.1 %	$ 28.3 B	USA
Illumina ILMN	142	$ 119.28	0.29 %	$ 19 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 198.94	-0.38 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Agilent Technologies A	111	$ 111.83	0.28 %	$ 34 B	USA
BioNano Genomics BNGO	225	$ 1.11	-	$ 1.41 M	USA
DarioHealth Corp. DRIO	207	$ 8.42	-6.44 %	$ 239 M	Israel
Lantheus Holdings LNTH	97.3	$ 78.5	-1.25 %	$ 5.3 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	299	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	50.4	$ 453.64	0.72 %	$ 13.1 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 198.71	2.13 %	$ 24.7 B	Schweiz
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Neogen Corporation NEOG	150	$ 9.11	0.22 %	$ 1.98 B	USA
National Research Corporation NRC	29.4	$ 17.4	5.33 %	$ 389 M	USA
NeoGenomics NEO	82.4	$ 8.24	4.57 %	$ 1.06 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 197.68	5.23 %	$ 19.5 B	USA
OPKO Health OPK	242	$ 1.19	-	$ 826 M	USA
Pacific Biosciences of California PACB	185	$ 1.36	2.26 %	$ 408 M	USA